ASTHMAXcel Voice Study
Conducting a Randomized Controlled Trial for A Novel Patient-Facing Mobile Platform to Collect and Implement Patient-Reported Outcomes and Voice Biomarkers in Underserved Adult Patients With Asthma
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 18 Years and older
- Sex
- All sexes
- Healthy volunteers
- Not accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
Not stated in the study description — ask the study team about visits and procedures.
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study compares ASTHMAXcel Voice with usual care for people with ongoing asthma who take daily medicine to control it. Researchers want to learn if it improves asthma care, quality of life, taking medicine as directed, and confidence in managing asthma.
The objective of this study is to conduct a randomized controlled trial (RCT) to compare the adapted and refined ASTHMAXcel Voice platform to usual care (UC). It is hypothesized by the investigator team that ASTHMAXcel Voice will be associated with improved clinical and process outcomes, asthma quality of life (QOL), medication adherence, and self-efficacy as compared to UC.
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Speak English.
- Have ongoing asthma diagnosed by a health care provider and take daily medicine to control it.
- Be able to understand the study and agree to take part.
- Have access to an iPhone or Android smartphone with a data plan.
Who can't join
- Are pregnant.
- Have severe mental health, thinking, or memory problems that would prevent you from completing the study steps.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * English speaking * Persistent asthma (diagnosed by a healthcare provider) on a daily controller medication * Able to provide informed consent * Smartphone access (iOS or Android) with data plan Exclusion Criteria: * Pregnancy * Severe psychiatric or cognitive problems that would prohibit completion of protocol
Study sites (1)
NY
- Montefiore Medical Center · The Bronx, NY 10467Sunit Jariwala, MD · Study contact · 609-937-1023 · sjariwal@montefiore.orgJuliana D Rodriguez, MD · Study contact · 718-862-1722 · juliana.rodríguez@einsteinmed.eduJonathan M Feldman, PhD · Sub-investigatorMore trials in The Bronx